These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28824332)

  • 1. Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X.
    Haraldsson S; Klarskov L; Nilbert M; Bernstein I; Bonde J; Holck S
    BMC Clin Pathol; 2017; 17():11. PubMed ID: 28824332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
    Zhao SM; Zhu XZ; Ji Y; Hou J
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.
    Dominguez-Valentin M; Therkildsen C; Veerla S; Jönsson M; Bernstein I; Borg A; Nilbert M
    PLoS One; 2013; 8(8):e71755. PubMed ID: 23951239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer.
    Therkildsen C; Jönsson G; Dominguez-Valentin M; Nissen A; Rambech E; Halvarsson B; Bernstein I; Borg K; Nilbert M
    Eur J Cancer; 2013 Apr; 49(6):1226-35. PubMed ID: 23245329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome.
    Klarskov L; Holck S; Bernstein I; Nilbert M
    J Clin Pathol; 2012 Apr; 65(4):352-6. PubMed ID: 22287689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Colorectal Cancer Type X (FCCTX) and the correlation with various genes-A systematic review.
    Nejadtaghi M; Jafari H; Farrokhi E; Samani KG
    Curr Probl Cancer; 2017; 41(6):388-397. PubMed ID: 29096939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
    Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
    Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological differences between familial colorectal cancer type X and sporadic cancer in an isolated area of spain.
    Medina-Arana V; Rahy-Martín A; Delgado-Plasencia L; Martínez-Riera A; León-Ayllón D; Rodríguez-Castellano D; Bravo-Gutiérrez A; Fernández-Peralta A; González-Aguilera JJ
    Colorectal Dis; 2016 Nov; 18(11):O388-O396. PubMed ID: 27671100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins.
    Walsh MD; Cummings MC; Pearson SA; Clendenning M; Walters RJ; Nagler B; Hopper JL; Jenkins MA; Suthers GK; Goldblatt J; Tucker K; Gattas MR; Arnold JL; Parry S; Macrae FA; McGuckin MA; Young JP; Buchanan DD
    Mod Pathol; 2013 Jul; 26(7):944-54. PubMed ID: 23370770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison Between Familial Colorectal Cancer Type X and Lynch Syndrome: Molecular, Clinical, and Pathological Characteristics and Pedigrees.
    Xu Y; Li C; Zhang Y; Guo T; Zhu C; Xu Y; Liu F
    Front Oncol; 2020; 10():1603. PubMed ID: 32984025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer.
    Shiovitz S; Copeland WK; Passarelli MN; Burnett-Hartman AN; Grady WM; Potter JD; Gallinger S; Buchanan DD; Rosty C; Win AK; Jenkins M; Thibodeau SN; Haile R; Baron JA; Marchand LL; Newcomb PA; Lindor NM;
    Br J Cancer; 2014 Jul; 111(3):598-602. PubMed ID: 24918813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X.
    Sánchez-Tomé E; Rivera B; Perea J; Pita G; Rueda D; Mercadillo F; Canal A; Gonzalez-Neira A; Benitez J; Urioste M
    J Gastroenterol; 2015 Jun; 50(6):657-66. PubMed ID: 25381643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer.
    Chen CH; Sheng Jiang S; Hsieh LL; Tang R; Hsiung CA; Tsai HJ; Chang IS
    Clin Transl Gastroenterol; 2016 Dec; 7(12):e208. PubMed ID: 27977020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
    Cathro HP; Mills SE
    Am J Surg Pathol; 2004 Aug; 28(8):1026-32. PubMed ID: 15252308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression.
    Rossi G; Murer B; Cavazza A; Losi L; Natali P; Marchioni A; Migaldi M; Capitanio G; Brambilla E
    Am J Surg Pathol; 2004 Apr; 28(4):442-52. PubMed ID: 15087663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic Pitfall.
    Neri G; Arpa G; Guerini C; Grillo F; Lenti MV; Giuffrida P; Furlan D; Sessa F; Quaquarini E; Viglio A; Ubezio C; Pasini A; Ferrero S; Sampietro G; Ardizzone S; Latella G; Mescoli C; Rugge M; Zingone F; Barresi V; Ciccocioppo R; Pedrazzoli P; Corazza GR; Luinetti O; Solcia E; Paulli M; Di Sabatino A; Vanoli A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.
    Choi YH; Lakhal-Chaieb L; Kröl A; Yu B; Buchanan D; Ahnen D; Le Marchand L; Newcomb PA; Win AK; Jenkins M; Lindor NM; Briollais L
    J Natl Cancer Inst; 2019 Jul; 111(7):675-683. PubMed ID: 30380125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.